Literature DB >> 11018123

Role of cytotoxic T lymphocytes in Epstein-Barr virus-associated diseases.

R Khanna1, S R Burrows.   

Abstract

Adaptation of persistent infection within the cells of the immune system is a unique characteristic of gamma herpes viruses. A classic example of this is Epstein-Barr virus (EBV), which may have co-evolved with Homo sapiens over millions of years, thus achieving a balance between viral persistence and immune control. In this review, we present an overview of virus and the host immune system interactions that regulate the life-long host-virus relationship in healthy virus carriers and EBV-associated diseases. Extensive analysis of cytotoxic T lymphocyte-mediated immune responses in healthy virus carriers has revealed unique mechanisms used by EBV to maintain a benign persistent state in vivo. On the other hand, this relationship in EBV-associated diseases favors the escape of the virus from the hostile effects of the immune response. This escape is achieved by either down-regulating the expression of highly immunogenic antigens of the virus or by direct modulation of the host cytotoxic T lymphocyte response by virus-encoded proteins.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11018123     DOI: 10.1146/annurev.micro.54.1.19

Source DB:  PubMed          Journal:  Annu Rev Microbiol        ISSN: 0066-4227            Impact factor:   15.500


  61 in total

1.  RelB nuclear translocation mediated by C-terminal activator regions of Epstein-Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells.

Authors:  Saparna Pai; Brendan J O'Sullivan; Leanne Cooper; Ranjeny Thomas; Rajiv Khanna
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

2.  Antibody to a lytic cycle viral protein decreases gammaherpesvirus latency in B-cell-deficient mice.

Authors:  Shivaprakash Gangappa; Sharookh B Kapadia; Samuel H Speck; Herbert W Virgin
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

3.  Regression of Epstein-Barr virus-induced B-cell transformation in vitro involves virus-specific CD8+ T cells as the principal effectors and a novel CD4+ T-cell reactivity.

Authors:  Nancy H Gudgeon; Graham S Taylor; Heather M Long; Tracey A Haigh; Alan B Rickinson
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

4.  CD4+ T-cell responses to Epstein-Barr virus nuclear antigen EBNA1 in Chinese populations are highly focused on novel C-terminal domain-derived epitopes.

Authors:  C W Tsang; X Lin; N H Gudgeon; G S Taylor; H Jia; E P Hui; A T C Chan; C K Lin; A B Rickinson
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

5.  Acquisition of polyfunctionality by Epstein-Barr virus-specific CD8+ T cells correlates with increased resistance to galectin-1-mediated suppression.

Authors:  Corey Smith; Leone Beagley; Rajiv Khanna
Journal:  J Virol       Date:  2009-04-08       Impact factor: 5.103

6.  Cytotoxic T cell adoptive immunotherapy as a treatment for nasopharyngeal carcinoma.

Authors:  Viviana P Lutzky; Pauline Crooks; Leanne Morrison; Natasha Stevens; Joanne E Davis; Monika Corban; David Hall; Benedict Panizza; William B Coman; Scott Coman; Denis J Moss
Journal:  Clin Vaccine Immunol       Date:  2013-12-18

7.  Investigation of epstein-barr virus as a potential cause of B-cell non-Hodgkin lymphoma in a prospective cohort.

Authors:  Anneclaire J De Roos; Otoniel Martínez-Maza; Keith R Jerome; Dana K Mirick; Kenneth J Kopecky; Margaret M Madeleine; Larry Magpantay; Kerstin L Edlefsen; Andrea Z Lacroix
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2013-07-24       Impact factor: 4.254

8.  Protective antigen-independent CD8 T cell memory is maintained during {gamma}-herpesvirus persistence.

Authors:  Stephanie S Cush; Emilio Flaño
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

9.  Functionally active virus-specific T cells that target CMV, adenovirus, and EBV can be expanded from naive T-cell populations in cord blood and will target a range of viral epitopes.

Authors:  Patrick J Hanley; Conrad Russell Young Cruz; Barbara Savoldo; Ann M Leen; Maja Stanojevic; Mariam Khalil; William Decker; Jeffrey J Molldrem; Hao Liu; Adrian P Gee; Cliona M Rooney; Helen E Heslop; Gianpietro Dotti; Malcolm K Brenner; Elizabeth J Shpall; Catherine M Bollard
Journal:  Blood       Date:  2009-05-14       Impact factor: 22.113

10.  Identification of Epstein-Barr virus strain variants in hairy leukoplakia and peripheral blood by use of a heteroduplex tracking assay.

Authors:  Diane Sitki-Green; Rachel H Edwards; Jennifer Webster-Cyriaque; Nancy Raab-Traub
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.